FitBionic develops consumer-centered prosthetics, with its first commercial product the FitBionic Foot. The company emphasizes amputee wellness and targets the growing diabetic population. Development of the FitBionic Foot was supported by a $1.2 million NIH grant, and the product has won multiple design awards and national recognition. FitBionic combines designers, technologists, and entrepreneurs from leading bionics and prosthetics companies and is based in Boulder, Colorado. Management includes CEO Eythor Bender and founder/CTO Jerome Rifkin; investors are joining the board as the company scales. FitBionic is preparing a global launch of the FitBionic Foot and is using recent financing as a bridge to a planned Series A in 2014.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Aug 2013